Predictors of nonadherence to continuation and maintenance antidepressant medication in patients with remitted recurrent depression

J Clin Psychiatry. 2009 Jan;70(1):63-9. doi: 10.4088/jcp.08m04119. Epub 2008 Dec 30.

Abstract

Objective: To identify predictors of nonadherence to continuation and maintenance antidepressant medication among patients with remitted recurrent depression.

Method: We used data of 91 remitted, recurrently depressed patients (at least 2 major depressive episodes as assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders) treated with continuation and maintenance antidepressant medication in a 2-year prospective study. Patients were recruited at psychiatric centers and through media announcement from February 2000 through September 2000. Adherence was assessed with the Medication Adherence Questionnaire. Nonadherence on this scale indicates that patients missed 20% or more of their antidepressant medication. We determined nonadherence point prevalences at the 7 assessment points. Based upon these 7 assessments, we found nonadherence percentages ranging from 39.7% to 52.7% with a mean of 46.5% over 2 years. We examined a set of potential risk factors (patient-related, disease-related, and treatment-related) measured at baseline.

Results: In univariate analysis using a stringent significance level (p <or= .005), we found no independently related predictors of nonadherence over a 2-year period. In a multivariate analysis with backward elimination, the baseline predictors for nonadherence over a 2-year period were a higher level of personality pathology and a higher level of education.

Conclusion: There are no clear predictors of nonadherence to antidepressants in the continuation and maintenance phases in remitted, recurrently depressed patients. Further research should focus on the process of becoming nonadherent to antidepressants in the longest phase of antidepressant use to maximize the potential protective effect of these medications.

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antidepressive Agents / administration & dosage*
  • Antidepressive Agents / adverse effects
  • Cognitive Behavioral Therapy
  • Combined Modality Therapy
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / epidemiology
  • Depressive Disorder, Major / psychology
  • Female
  • Humans
  • Long-Term Care
  • Male
  • Middle Aged
  • Netherlands
  • Patient Compliance / psychology*
  • Patient Compliance / statistics & numerical data
  • Prospective Studies
  • Risk Factors
  • Secondary Prevention

Substances

  • Antidepressive Agents